SignatureFD’s Xeris Biopharma Holdings XERS Stock Holding History

SignatureFD’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.66K	Sell	631 -89	-12%	-$590	﹤0.01%	2879
2025 Q4	$5.65K	Buy	720 +89	+14%	+$700	﹤0.01%	2646
2025 Q3	$5.14K	Hold	631	–	–	﹤0.01%	2653
2025 Q2	$2.95K	Buy	631 +240	+61%	+$1.1K	﹤0.01%	2759
2025 Q1	$2.15K	Buy	+391	New	+$1.58K	﹤0.01%	2854
2022 Q2	–	Sell	-1,445	Closed	-$4K	–	3366
2022 Q1	$4K	Buy	+1,445	New	+$3.53K	﹤0.01%	2628

Other funds holding XERS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SignatureFD's XERS Position: Q1 2026 in Review

SignatureFD reduced its Xeris Biopharma Holdings (XERS) stake by 12% in Q1 2026, selling an estimated $590 and leaving 631 shares worth $3.66K. The position accounts for ﹤0.01% of the portfolio, ranked #2879.

SignatureFD first reported a position in XERS in Q1 2022 and has held it in 6 quarters since. The position peaked at $5.65K in Q4 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

SignatureFD held 631 shares of Xeris Biopharma Holdings worth $3.66K as of Q1 2026.
SignatureFD sold 89 Xeris Biopharma Holdings shares in Q1 2026, an estimated $590.
Xeris Biopharma Holdings made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #2879 holding.
SignatureFD first reported a position in Xeris Biopharma Holdings in Q1 2022 and has held it in 6 quarters since.
SignatureFD's Xeris Biopharma Holdings position peaked at $5.65K in Q4 2025.
237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.